Atai stock forecast.

Find the latest COMPASS Pathways plc (CMPS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Atai Life Sciences has a strong pipeline of drugs for the next 18 months, and will pursue aggressive growth. The company had $335 million in cash as of May 2022, which is roughly 50% of its ...06:48 PM ET 11/23/2020. Atai Life Sciences, a company that backs Compass Pathways ( CMPS) and other psychedelic drug developers, said Monday that it had closed a $125 million funding round, the ...What is the current Price Target and Forecast for atai Life Sciences (ATAI) atai Life Sciences (ATAI) (Delayed Data from NSDQ) $1.12 USD +0.08 (7.69%) Updated …Web

As such, ATAI has been trading -1490.91% off suggested target high and -286.36% from its likely low. ATAI Life Sciences N.V. (ATAI) estimates and forecasts. Looking at statistics comparing ATAI Life Sciences N.V. share performance against respective industry, we note that the company has outperformed competitors.

ATAI Life Sciences NV. $1.12. ATAI 7.69% ; Enveric Biosciences Inc. $1.68. ENVB 13.51% ; Compass Pathways PLC. $6.10. CMPS 2.01% ; ehave Inc. $0.0017. EHVVF 0.00%.Jul 10, 2023 · On July 10, 2023, the stock experienced a significant increase, driven by positive forecasts and a strong consensus among investment analysts. According to data from CNN Money, the 12-month price forecasts for ATAI stock have a median target of 11.00, with a high estimate of 21.00 and a low estimate of 6.00.

25. 5. 2023. ... As of May 24, 2023, ATAI Life Sciences boasts an average one-year price target of $13.75, as predicted by industry analysts. These forecasts ...Dec 15, 2022 · What's Happening With ATAI Life Sciences NV Stock Today? ATAI Life Sciences NV (ATAI) stock is trading at $3.05 as of 3:20 PM on Thursday, Dec 15, a drop of -$0.05, or -1.77% from the previous closing price of $3.10. The stock has traded between $2.98 and $3.10 so far today. Volume today is low. ACIU Stock 12 Months Forecast. Based on 2 Wall Street analysts offering 12 month price targets for AC Immune SA in the last 3 months. The average price target is $16.00 with a high forecast of $16.00 and a low forecast of $16.00. The average price target represents a 417.80% change from the last price of $3.09.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.

Mar 31, 2023 · Atai Life Sciences ( ATAI 2.80%), a small-cap drugmaker developing psychedelic-based treatments for drug dependency and mental health disorders, posted strong gains during the first four days of ...

NEW YORK and BERLIN, Jan. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “the Company”), a clinical-stage biopharmaceutical company focused on mental health ...

Find the latest Atai Life Sciences N.V. (ATAI) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Atai tumbled 32% to $6.82 per share, extending Tuesday’s slide into a second day. The stock is down about 55% from its June initial public offering price of $15. “It is imperative for me to be ...Next reporting date. February 26, 2024. EPS forecast (this quarter) $0.34. Annual revenue (last year) $960.5M. Annual profit (last year) $40.4M. Net profit margin.The ATAI Life Sciences N.V. stock forecast is 6.0790759618269 USD for 2024 November 11, Monday; and 24.831 USD for 2028 November 11, Saturday with technical analysis. ATAI Life Sciences N.V. (ATAI) stock price prediction is 6.0790759618269 USD.ALZN Stock 12 Months Forecast. $3.75. (160.42% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Alzamend Neuro in the last 3 months. The average price target is $3.75 with a high forecast of $6.50 and a low forecast of $1.00. The average price target represents a 160.42% change from the last price of $1.44.Find the latest TeraWulf Inc. (WULF) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...

5 Top Websites for Stock Forecasts. Swati Goyal. Story Highlights. When investors talk about top websites for stock forecasts, their focus is on finding the best investment research service. Researching stocks is a major cornerstone of successful investing, and here you’ll find websites that can make your work easy. Share.Stock Price Forecast The 6 analysts offering 12-month price forecasts for Ouster Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 6.00.Find the latest Atai Life Sciences N.V. (ATAI) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.This stake is worth roughly $98M as of Tuesday, March 28, based on COMPASS Pathways’ closing price of $10.23/share on that day. You can find atai’s filed 10-K from last Friday here. With ...30. 8. 2022. ... Wall Street's 12-month median price forecast for ATAI stock stands at $24.50. Compass Pathways (CMPS). magic mushrooms representing champion ...These forecasts range from $9 to $20, indicating a considerable increase compared to its previous closing price of $1.88. Over the past 12 months, ATAI’s stock has witnessed a remarkable growth ...Dec 1, 2023 · ATAI Life Sciences NV ATAI Morningstar Rating Unlock Stock XNAS Rating as of Nov 29, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating...

A list of all stock splits on the US stock market in 2023, including both regular (forward) and reverse splits.

Stock Price Forecast The 6 analysts offering 12-month price forecasts for Ouster Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 6.00.ATAI Life Sciences NV Stock Forecast. Is ATAI Life Sciences NV Stock Undervalued? The current ATAI Life Sciences NV [ ATAI] share price is $1.06. The Score for ATAI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. ATAI is currently trading in the 10-20% percentile range relative to its historical ...Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $214.15M. -60.0%. Market Cap / Employee. The market cap of a ...Find the latest Global Partners LP (GLP) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Stock analysis for ATAI Life Sciences NV (ATAI:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...Exela Technologies Inc () Stock Market info Recommendations: Buy or sell Exela Technologies stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Exela Technologies share forecasts, stock quote and buy / sell signals below.According to present data Exela Technologies's XELA shares and potentially its …Atai Capital experienced a decline of 5.8% in the third quarter, bringing our year-to-date (YTD) returns to 6.5% net of all fees. This compares to a 13.1% total return for the S&P 500 YTD and a 2. ...atai Life Sciences N.V. - Buy. Zacks' proprietary data indicates that atai Life Sciences N.V. is currently rated as a Zacks Rank 2 and we are expecting an above average return from the ATAI shares ...The total addressable market for AI is massive; by 2030, it's expected to be worth nearly $2 trillion, according to Statista. That's a massive pie, and multiple companies will be vying for these ...

ATAI Life Sciences. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01 ...

A list of all stock splits on the US stock market in 2023, including both regular (forward) and reverse splits.

ATAI Life Sciences N.V. analyst ratings, historical stock prices, earnings estimates & actuals. ATAI updated stock price target summary. Their CMPS share price targets range from $19.00 to $120.00. On average, they anticipate the company's stock price to reach $46.83 in the next year. This suggests a possible upside of 683.2% from the stock's current price. View analysts price targets for CMPS or view top-rated stocks among Wall Street analysts.Description. بايثون هي واحده من اكثر لغات البرمجه انتشارا في العالم واسهلهم واقواهم. اللعه مستخدمه تقريبا في اغلب التطبيقات اللي بنستخدمها في حياتنا اليوميه زي Youtube , Google Search , Instagram , Quora , Pinterest ...Get ATAI Life Sciences NV (ATAI.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsAbout the ATAI Life Sciences N.V. stock forecast. As of 2023 November 11, Saturday current price of ATAI stock is 1.160$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. ATAI Life Sciences N.V. stock price has been showing a declining tendency so we believe that similar market segments …21. 6. 2023. ... Recent price, YTD Change, Market value (mil), Average price target, Implied ... ATAI Life Sciences / ATAI, 1.78, -31.2, 303.8, 12.30, 593. Caribou ...NEW YORK and BERLIN, Jan. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “the Company”), a clinical-stage biopharmaceutical company focused on mental health ...SOFI - SoFi Technologies Inc Stock quote - CNNMoney.comShares of the Peter Thiel -backed psychedelic start-up Atai Life Sciences jumped Friday on their first day of trading on Wall Street. The newly listed Nasdaq stock opened up 40% before pulling ...Find the latest SoundHound AI, Inc. (SOUN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...

Atai Capital experienced a decline of 5.8% in the third quarter, bringing our year-to-date (YTD) returns to 6.5% net of all fees. This compares to a 13.1% total return for the S&P 500 YTD and a 2. ...Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $214.15M. -60.0%. Market Cap / Employee. The market cap of a ...On Friday 11/24/2023 the closing price of the ATAI Life Sciences N.V. Registered Shs share was $1.10 on NAS. Compared to the opening price on Friday 11/24/2023 on NAS of $1.12, this is a drop of 1 ...Jul 28, 2022 · Atai Life Sciences. One of Atai Life Sciences' early investors was venture capitalist Peter Thiel. The company went public in June 2021 at $15 and is currently trading at $3.78 with a market cap ... Instagram:https://instagram. top gap insurance companiesklip etftd ameritrade for dummieschina msci View a financial market summary for ATAI including stock price quote, trading volume, volatility, options volume, statistics, and other important company ...Since Atai Life Sciences is only going public, we don’t have any forecast for the stock. Also, being a clinical-stage company, we don’t have earnings-based metrics to value the stock. best gold brokersflorida va mortgage Atai Life Sciences (ATAI) Stock Forecast & Price Target $1.10 +0.01 (+0.92%) (As of 11/24/2023 ET) Compare Today's Range $1.08 $1.12 50-Day Range $1.06 $1.52 52 …Web ngg futures NEW YORK and BERLIN, Jan. 06, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “the Company”), a clinical-stage biopharmaceutical company focused on mental health ...Atai Life Sciences N.V. Market Cap: 184.27M, Enterprise value: 101.26M, P/E: -1.93, PEG ratio: -0.17, EPS: -0.42, Revenue: 334K, EBITDA: -129.47M, ...Atai Life Sciences is forecasted to grow earnings and revenue by 20.7% and 73.6% per annum respectively. EPS is expected to grow by 29.2%. Return on equity is forecast to be -69.3% in 3 years.